The Cholangiocarcinoma Market Is Estimated To Increase At A CAGR Of 12.8 Percent During The Forecast Period 2021-2028
Cholangiocarcinoma is cancer that develops in the bile ducts, which transport the digesting fluid bile. Cholangiocarcinoma is caused by a variety of factors that are unknown at this time. The malignant tumor can grow from any part of the bile duct, including the terminal ductules (Canals of Hering) to the ampulla of Vater and the peribiliary glands (intramural and intramural) extramural), and it can occasionally damage the gallbladder. In 2021, the global Cholangiocarcinoma Market is predicted to be worth US$ 185.4 million, growing at a CAGR of 12.8 percent over the forecast period (2021-2028). Over the forecast period, the worldwide cholangiocarcinoma market is expected to rise due to rising cholangiocarcinoma prevalence. COVID-19 has three primary effects on the economy: it directly affects production and demand, disrupts distribution routes, and has a financial impact on businesses and financial markets. In addition, several countries, including China, India, Saudi Arabia, the Unit